首页> 外文期刊>Obstetrical and gynecological survey >Periconceptional intake of vitamins and fetal death: A cohort study on multivitamins and folate
【24h】

Periconceptional intake of vitamins and fetal death: A cohort study on multivitamins and folate

机译:围产期维生素的摄入与胎儿死亡:多种维生素和叶酸的队列研究

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Because fetal development requires energy and micronutrients, periconceptional use of multivitamins may be beneficial. Supplementation with folate has been recommended before and early in pregnancy to decrease the risk for neural tube defects, but the use of periconceptional multivitamins is controversial. Data from the Danish National Birth Cohort were used to examine the association between periconceptional multivitamin or folate-only use and risk for early and late fetal death. The Danish National Birth Cohort maintains data on 100,419 pregnancies in 92,374 women recruited in 1996 to 2002. The final study cohort comprised 35,914 pregnancies in 35,172 women. Women reported on supplement use by type and frequency during a 12-week periconceptional period, divided into a 6-week preconception and a 6-week postconception period and categorized as weeks 1 to 2, 3 to 4, and 5 to 6 relative to the two 6-week periods. Different patterns of multivitamin use were based on no, partial (1-3 weeks), or regular use (4-6 weeks) in either 6-week period. The associations between periconceptional multivitamin or folate use and early (<20 weeks) and late (>20 weeks) fetal death were estimated by hazard ratios (HRs) with 95% confidence intervals (CIs). Comparisons were made between supplement use or not at any time during the periconceptional period.
机译:由于胎儿的发育需要能量和微量营养素,因此,按避孕法使用多种维生素可能有益。已建议在怀孕前和怀孕初期补充叶酸,以减少神经管畸形的风险,但围产期多种维生素的使用引起争议。丹麦国家出生队列的数据被用来检验围孕期仅使用多种维生素或仅使用叶酸与胎儿早期和晚期死亡风险之间的关系。丹麦国家出生队列保留了1996年至2002年招募的92,374名妇女中100,419例怀孕的数据。最后的研究队列包括35,172名妇女中的35,914例怀孕。妇女报告了在受孕十二周期间按类型和频率进行的补充剂使用,分为受孕前6周和受孕后6周,相对于受精卵,妇女分为1至2周,3至4周和5至6周。两个6周的时间段。在6周内没有,部分(1-3周)或定期使用(4-6周)的多种维生素使用方式有所不同。围孕期使用多种维生素或叶酸与早(<20周)和晚(> 20周)胎儿死亡之间的关联通过危险比(HR)和95%置信区间(CI)进行估算。在围孕期的任何时候都对补充剂的使用与否进行了比较。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号